AP NEWS
Press release content from ACCESSWIRE. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from ACCESSWIRE
Press release content from ACCESSWIRE. The AP news staff was not involved in its creation.

HollyWeed North Manufacturing & Extracts Inc. (a Subsidiary of HollyWeed North Cannabis Inc.) Receives Cannabis Processing License and Launches Their First Manufacturing Line

January 10, 2019
VICTORIA, BC / ACCESSWIRE / January 10, 2019 / Renee Gagnon, Founder and CEO of HollyWeed North Cannabis Inc.today announced that HollyWeed Manufacturing & Extracts Inc.(a subsidiary of HollyWeed North Cannabis Inc.) have been issued their

VICTORIA, BC / ACCESSWIRE / January 10, 2019 / Renee Gagnon, Founder and CEO of HollyWeed North Cannabis Inc.today announced that HollyWeed Manufacturing & Extracts Inc.(a subsidiary of HollyWeed North Cannabis Inc.) have been issued their Federal Processing Licence from Health Canada on December24, 2018.

As licensed under Health Canada Controlled Drugs and Substances Act, HollyWeed Manufacturing and Extracts Inc.(HWNM&E) a subsidiary of HollyWeed North Cannabis Inc.Canada will be launching their first manufacturing line devoted to the production of CBD, THC and CBD/THC concentrated oil, bottled oil and bulk oil.HWNM&E was issued a Health Canada Dealer License (Security Level 8) in June 2018 which has now been transitioned to a Standard Processing License effective Dec 24, 2018 under the new Cannabis Act. HollyWeed’s operations and corporate strategy is led by executives with extensive experience in the heavily regulated pharmaceutical industry and cannabis industry.

In making the announcement, Gagnon stated: “This license is the product of an entire teams life experience in pharma and QA.I’m proud to have the absolute best team in Cannabis”

About HollyWeed North Cannabis Inc.: HollyWeed North operates as licenser and publisher of their partner’s intellectual properties (recipes, formulas, etc.) and distributes products within legal jurisdictions, extending partner brands into multiple markets.

They provide cross-border cannabis product research, development, licensing and legal production services for individuals, companies, and associations.Their goal is to provide continuous quality and compliance oversight in all areas of business operations to exceed regulatory requirements. Holly Weed North and TerraCube Inc.were both founded by Renee M.Gagnon, founder of one of Canadas first Licensed Producers (EMH.V), and the first female CEO of a publicly-traded federally licensed Cannabis Company (2015).Hollyweed North Cannabis Inc., TerraCube and Minicube are trademarks of their respective owners.

This press release contains projections and other forward-looking statements regarding future events or our future financial performance.All statements other than present and historical facts and conditions contained in this release, including any statements regarding our future results of operations and financial positions, business strategy, plans and our objectives for future operations, are forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended).These statements are only predictions and reflect our current beliefs and expectations with respect to future events and are based on assumptions and subject to risk and uncertainties and subject to change at any time.We operate in a very competitive and rapidly changing environment.New risks emerge from time to time.Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements.Actual events or results may differ materially from those contained in the projections or forward-looking statements.Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: (i) the contraction or lack of growth of markets in which we compete and in which our products are sold (ii) unexpected increases in our expenses, including manufacturing expenses, (iii) our inability to adjust spending quickly enough to offset any unexpected revenue shortfall, (iv) delays or cancellations in spending by our customers, (v) unexpected average selling price reductions, (vi) the significant fluctuation to which our quarterly revenue and operating results are subject due to cyclicality in the wireless communications industry and transitions to new process technologies, (vii) our inability to anticipate the future market demands and future needs of our customers, (viii) our inability to achieve new design wins or for design wins to result in shipments of our products at levels and in the timeframes we currently expect, (ix) our inability to execute on strategic alliances, (x) the impact of natural disasters on our sourcing operations and supply chain, and(xi) other factors detailed in documents we file from time to time with the Securities and Exchange Commission.Forward-looking statements in this release are made pursuant to the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995.

Contact: Deborah Radel at DRPR,

SOURCE: HollyWeed North Cannabis Inc.